Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Total revenue $ 326,623 $ 356,804
Cost of goods sold 34,984 28,365
Gross profit 291,639 328,439
Operating expenses:    
Employee compensation and contractors 129,422 382,071
Selling, general, and administrative (includes royalty of $105,000 and $75,000 to related party for the three months ended March 31, 2021 and 2020, respectively) 3,016,277 912,240
Research and development 130,825 77,876
Total operating expenses 3,276,524 1,372,187
Loss from operations (2,984,885) (1,043,748)
Other income (expense):    
Interest expense (67,817) (188,637)
Discount amortization (31,945)  
Private placement (262,000)
Change in fair value derivative 135,139
Other income and expense, net (99,762) (315,498)
Net loss (3,084,647) (1,359,246)
Net loss attributable to noncontrolling interest 136,161
Net loss attributable to Quanta, Inc. $ (2,948,486) $ (1,359,246)
Net loss per share, basic and diluted $ (0.05) $ (0.02)
Weighted average common shares outstanding - basic and diluted 63,300,000 39,200,090
Sales, Net [Member]    
Total revenue $ 318,807 $ 350,349
License Revenue [Member]    
Total revenue $ 7,816 $ 6,455